Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Buod ng balita
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Subaybayan ang mga pinakabagong balita mula sa mapagkakatiwalaang publisher na may maiikling buod. Buksan ang orihinal na link para sa detalye.